• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Update of Administrative Measures for the Clinical Use of Medical Devices

Update of Administrative Measures for the Clinical Use of Medical Devices

Wednesday, 24 March 2021 / Published in Medical Device, News, NMPA Registration in China

Update of Administrative Measures for the Clinical Use of Medical Devices

On February 4, 2021, the NHC (National Health Commission) announced (No.8-2021) the implementation of the Administrative Measures for the Clinical Use of Medical Devices coming into force from March 1, 2021 onwards. This legislation formalizes as a higher level regulation of the previously implemented Code.

Background

The Code of Practice for the Safe and Clinical Use of Medical Devices was published (No.4-2010) in 2010. Based on the experiences gained from the management of clinical use of medical device in the past, the new measure enhances the safety and effective use of medical devices and acts as a regulatory guidance for health authorities.

Purpose of the New Measure

  • Strengthen the management of the clinical use of medical devices
  • Ensure the safe and effective clinical use of medical devices
  • Clarify the roles and responsibilities between the national health authorities and local health authorities in terms of the supervision and the management of medical devices
  • Clarify the responsibilities of the person in charge of the medical institution

Requirements for Medical Institutions

  • Establish a risk management system for the clinical use of medical devices
  • Implement a monitoring and reporting system for priority medical devices (e.g., life-support devices)
  • Keep medical records for large, implantable and interventional medical devices
  • Carry out evaluations on the clinical use of medical devices
  • Terminate all related operations of the medical device if any safety risks are identified and call for maintenance

Supervision and Management

  • Medical institutions will be penalized correspondingly for violating the newly addressed measures

 By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Clinical Use of Medical Devices, Medical Devices

What you can read next

raw material change passive medical device
NMPA Provides Evaluation Guidance on Material Changes for Passive Medical Devices
17 New Implementation Rules Published For the CCC-Certification
Introducing QR code for the China Energy Label (CEL)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Cisema Webinar: Greater Bay Area Initiative and China NMPA Registration for Medtech

    On April 15, 2021, Cisema will cohost a webinar...
  • Cisema to attend CMEF 2021

    Once again, Cisema will be participating in the...
  • Cisema Webinar Series: NMPA Registration of Medical Devices in China

    In the first webinar of the series, we were del...
  • New Regulatory Updates Concerning Health Food Filing

    On February 20, 2021, the SAMR (State Administr...
  • New Regulatory Controls to Support the CSAR Including Animal Testing Exemptions

    On March 4, 2021, the NMPA announced the Provis...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP